Showing results (21-30 of 89) with videos related to
Sort By:
Pageof 9
Molecules (Basel, Switzerland)|February 21, 2017
Synthesis and Biological Evaluation of Novel 8-Morpholinoimidazo[1,2-a]pyrazine Derivatives Bearing Phenylpyridine/Phenylpyrimidine-CarboxamidesShan Xu, Chengyu Sun, Chen Chen, et al.Current Pharmaceutical Design|February 4, 2025
Advances in the Synthesis and SAR of Pyrido[2,3-d]pyrimidine ScaffoldXiongpiao Wei, Dang Fan, Haifeng Dong, et al.Journal of Biomolecular Structure & Dynamics|January 4, 2024
T6496 targeting EGFR mediated by T790M or C797S mutant: machine learning, virtual screening and bioactivity evaluation studyLinxiao Wang, Dang Fan, Wei Ruan, et al.European Journal of Medicinal Chemistry|November 27, 2020
The new opportunities in medicinal chemistry of fourth-generation EGFR inhibitors to overcome C797S mutationJie He, Zhihui Zhou, Xin Sun, et al.Bioorganic & Medicinal Chemistry|February 25, 2016
Design, synthesis, and docking studies of afatinib analogs bearing cinnamamide moiety as potent EGFR inhibitorsYuanbiao Tu, Yiqiang OuYang, Shan Xu, et al.Journal of Experimental & Clinical Cancer Research : CR|January 6, 2026
Targeting serine synthesis pathway to reverse paclitaxel resistance in NSCLC with combination of paclitaxel and anlotinibMengting Yu, Yanyun Hong, Qingshan Pan, et al.ACS Applied Materials & Interfaces|January 31, 2022
Biomineralized Cascade Enzyme-Encapsulated ZIF-8 Nanoparticles Combined with Antisense Oligonucleotides for Drug-Resistant Bacteria TreatmentYan Zhang, Luogen Lai, Yijun Liu, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 6, 2019
Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancersCaolin Wang, Shan Xu, Liang Peng, et al.Bioorganic Chemistry|April 5, 2021
Design, synthesis and evaluation of anti-proliferative activity of 2-aryl-4-aminoquinazoline derivatives as EGFR inhibitorsZhihui Zhou, Jie He, Feiyi Yang, et al.Molecules (Basel, Switzerland)|December 22, 2019
Design, Synthesis, and Biological Evaluation of Pyridineamide Derivatives Containing a 1,2,3-Triazole Fragment as Type II c-Met InhibitorsHehua Xiong, Jianxin Cheng, Jianqing Zhang, et al.Pageof 9